Ronald Hosking
Gründer bei PlantForm Corp.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Don Stewart | M | - |
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 16 Jahre |
| Mark Goldberg | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 16 Jahre |
| David Fraser | M | 67 |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | - |
| Bruce Clark | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 2 Jahre |
| Michael Wanner | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 2 Jahre |
| Grant Tipler | M | - |
Toronto Biotechnology Initiative
 Toronto Biotechnology Initiative BiotechnologyHealth Technology Toronto Biotechnology Initiative promotes growth of biotechnology. The company was founded in and is headquartered in Toronto, Canada. | - |
| Matt Buist | M | - |
Toronto Biotechnology Initiative
Toronto Biotechnology Initiative BiotechnologyHealth Technology Toronto Biotechnology Initiative promotes growth of biotechnology. The company was founded in and is headquartered in Toronto, Canada. | - |
| Anita Nador | F | - |
Toronto Biotechnology Initiative
Toronto Biotechnology Initiative BiotechnologyHealth Technology Toronto Biotechnology Initiative promotes growth of biotechnology. The company was founded in and is headquartered in Toronto, Canada. | - |
| David Cayea | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 13 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Andrew Michael Williams | M | 73 | 12 Jahre | |
| David Hill | M | - | 8 Jahre | |
| Nan Hutchinson | F | 62 | 2 Jahre | |
| Ilan Oren | M | 40 | 3 Jahre | |
| Perry B. Molinoff | M | 84 | 4 Jahre | |
| Alan D. C. Ryley | M | - | 8 Jahre | |
| Tomer Gold | M | 52 | 3 Jahre | |
| Rochelle Stenzler | F | 70 | 10 Jahre | |
| Kristen Galfetti | F | - | - | |
| Julia G. Levy | M | 89 | 5 Jahre | |
| Tamar Howson | F | 75 | 1 Jahre | |
| Alan Torrie | M | 73 | 7 Jahre | |
| Gregory M. Bokar | M | 62 | - | |
| Douglas Reynolds | M | - | - | |
| Eric J. Pappert | M | - | - | |
| Jordan Dubow | M | 46 | - | |
| Stephen L. Freeman | M | 56 | - | |
| Thierry Bilbault | M | 65 | 2 Jahre | |
| Fred Driscoll | M | 73 | - | |
| Thomas Picone | M | - | - | |
| Albert Agro | M | 59 | 6 Jahre | |
| David Pattenden | M | - | 4 Jahre | |
| Kenneth Hughes | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | - |
| Nathan Bryson | M | 61 | 5 Jahre | |
| Peter Palframan | M | - | 4 Jahre | |
| Donald J. P. Ziraldo | M | 75 | 5 Jahre | |
| J. Hall | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Kanada | 36 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Ronald Hosking
- Persönliches Netzwerk
